Cachexia News and Research

RSS
Cachexia is a condition which denotes the excessive loss of weight. It occurs because of the depletion of adipose tissue and muscle mass in people who are not trying to lose weight.
Myostatin responsible for initiation of muscle loss: Study

Myostatin responsible for initiation of muscle loss: Study

Scientists isolate previously unknown protein in skeletal muscle

Scientists isolate previously unknown protein in skeletal muscle

Positive interim data from XBiotech monoclonal antibody Phase II study for type 2 diabetes

Positive interim data from XBiotech monoclonal antibody Phase II study for type 2 diabetes

FDA grants Fast Track designation to XBiotech’s Xilonix for treatment of cachexia

FDA grants Fast Track designation to XBiotech’s Xilonix for treatment of cachexia

Karolinska Institutet professor receives Fernström Foundation Nordic Prize for obesity research

Karolinska Institutet professor receives Fernström Foundation Nordic Prize for obesity research

Aeterna Zentaris commences enrollment in AEZS-130 Phase 2A trial for cancer cachexia

Aeterna Zentaris commences enrollment in AEZS-130 Phase 2A trial for cancer cachexia

Bile duct cancer chosen as next indication for PCI Biotech

Bile duct cancer chosen as next indication for PCI Biotech

Results reported for clinical trial for the treatment of depression using external trigeminal nerve stimulation

Results reported for clinical trial for the treatment of depression using external trigeminal nerve stimulation

MEDVAMC initiates Aeterna Zentaris' AEZS-130 Phase 2A trial in cancer cachexia

MEDVAMC initiates Aeterna Zentaris' AEZS-130 Phase 2A trial in cancer cachexia

Cancer-related fatigue linked to muscle mass and strength

Cancer-related fatigue linked to muscle mass and strength

Tesco selects Cancer Research UK as Charity of the Year in 2012

Tesco selects Cancer Research UK as Charity of the Year in 2012

FDA grants IND for AEZS-130 Phase 2A trial in cancer cachexia

FDA grants IND for AEZS-130 Phase 2A trial in cancer cachexia

Helsinn begins enrollment in anamorelin Phase III trial for NSCLC-associated anorexia/cachexia

Helsinn begins enrollment in anamorelin Phase III trial for NSCLC-associated anorexia/cachexia

Symposium papers highlight role of oxidative stress in cardiovascular disease

Symposium papers highlight role of oxidative stress in cardiovascular disease

Scientists directly link lipid metabolism and cancer-associated cachexia

Scientists directly link lipid metabolism and cancer-associated cachexia

Multi-disciplinary collaboration proposes intravenous vitamin C for treatment of cancer

Multi-disciplinary collaboration proposes intravenous vitamin C for treatment of cancer

PsiOxus commences MT-102 Phase II study for treatment of cancer- and age-related wasting

PsiOxus commences MT-102 Phase II study for treatment of cancer- and age-related wasting

Vicus initiates VT-122 Phase 2 trial in advanced liver cancer, systemic inflammation and cachexia

Vicus initiates VT-122 Phase 2 trial in advanced liver cancer, systemic inflammation and cachexia

Myotec, Hybrid merge to form PsiOxus Therapeutics

Myotec, Hybrid merge to form PsiOxus Therapeutics

GTx third quarter net loss decreases to $8.6 million

GTx third quarter net loss decreases to $8.6 million